Skip to main content

Table 1 Characteristics of the studies selected for the meta-analysis

From: The prevalence of depression symptoms among infertile women: a systematic review and meta-analysis

ID Authors Year publication countries Income levels Sample size Type of infertility Prevalence of depression Age (Y)
(mean ± SD)
Mean years of infertility
(mean ± SD)
Type of Tools Quality assessment
1 Ramezanzadeh et al. [20] 2004 Iran Low and middle 370 Primary and secondary 40.80% 28 ± 5.37 6.36 ± 4.18 BDI 3/5
2 Alosaimi et al. [31] 2015 Saudi Arabia High 206 Primary and secondary 26.20% NA 5.4 ± 4.3 MINI 3/5
3 Maroufizadeh et al. [2] 2018 Iran Low and middle 649 Primary and secondary 33.90% 31/37 ± 5.69 5.62 ± 4.03 HADS 4/5
4 Joelsson et al. [32] 2017 Sweden High 468 Primary and secondary 15.70% 30.1 ± 4.8 1.8 ± 002 HADS 5/5
5 Lakatos et al. [33] 2017 Hungary High 134 Primary and secondary 44.80% 33.30 ± 4.85 3.61 ± 3.08 BDI 3/5
6 Yusuf [34] 2006 Pakistan Low and middle 100 Primary and secondary 79% 24.60 ± 5.40 NA DASS 3/5
7 Biringer et al. [35] 2015 Norway High 615 Primary and secondary 8.20% 35.15 ± 6.28 NA HADS 5/5
8 Upkong and Orgi [36] 2006 Nigeria Low and middle 112 Primary and secondary 42.90% 34.5 ± 5.5 4.46 ± 3.73 BDI 4/5
9 Rostad et al. [37] 2014 Norway High 1413 Primary and secondary 6.40% NA NA HADS 3/5
10 Verma et al. [38] 2015 India Low and middle 140 Primary and secondary 56.40% 28.70 ± 5.94 NA HADS 3/5
11 Kalkhoran et al. [39] 2011 Iran Low and middle 30 Primary and secondary 46.70% 29.2 0 ± 4.2 4.8 ± 0.5 BDI 3/5
12 Peyvandi et al. [40] 2009 Iran Low and middle 200 Primary and secondary 62.00% 33.39 ± 0.2 4.1 ± 0.6 BDI 4/5
13 Sulyman et al. [41] 2019   Nigeria 207 Primary and secondary 25.60% 29.60 ± 4.0 5.60 ± 2.1 HADS 4/5
14 Vo et al. [42] 2019 Vietnam Low and middle 401 Primary and secondary 12.20% 30.41 ± 4.47 3.10 ± 2.20 PHQ-9 4/5
15 Oladeji and OlaOlorun [43] 2018 Nigeria Low and middle 110 Primary and secondary 52.70% 34.50 ± 5.70 NA PHQ-9 3/5
16 Crawford et al. [25] 2017 USA High 416 Primary and secondary 41.00% 34.25 ± 4.20 2.50 ± 0.60 NIH-PROMIS 4/5
17 Al-Asadi and Hussein [44] 2015 Iraq Low and middle 251 Primary and secondary 68.90% 24.26 ± 8.5 NA ICD-10 4/5
18 Alhassan et al. [45] 2014 Ghana Low and middle 100 Primary and secondary 62.00% 30.50 ± 6.30 NA BDI 3/5
19 Haririan eta l [27] 2009 Iran Low and middle 100 Primary and secondary 85.00% 27.50 ± 4.40 7.01 ± 4.45 BDI 3/5
20 Chiaffarino et al. [46] 2011 Italy High 872 Primary and secondary 17.90% 35.25 ± 6.70 NA ZDS 4/5
21 Drosdzol and Skrzypulec [47] 2009 Poland High 206 Primary and secondary 35.44% 29.80 ± 4.10 NA BDI 4/5
22 Ma et al. [48] 2018 China Low and middle 98 Primary and secondary 47.00% 31.80 ± 4.80 NA ZDS 3/5
23 Wu et al. [49] 2014 China Low and middle 288 Primary and secondary 22.60% 33.30 ± 3.80 NA CES-D10 3/5
24 Naab et al. [24] 2013 Ghana Low and middle 203 Primary and secondary 11.00% 31.25 ± 4.62 3.40 ± 2.70 CES-D10 4/5
25 Kissi et al. [22] 2013 Tunisia Low and middle 100 Primary and secondary 33.00% 32.69 ± 4.91 5.19 ± 4.62 HADS 3/5
326 Pinar et al. [26] 2012 Turkey Low and middle 160 Primary and secondary 65.00% 25.23 ± 3.25 5.23 ± 3.42 BDI 3/5
27 Psaros et al. [50] 2012 USA High 104 Primary and secondary 63.00% 35.87 ± 0.4 NA BDI 3/5
28 Li et al. [51] 2016 China Low and middle 211 Primary and secondary 50.71% NA 2.80 ± 1.20 ZDS 4/5
29 Khademi et al. [52] 2004 Iran Low and middle 681 Primary and secondary 40.10% 27.78 ± 5.32 6.28 ± 3.83 BDI 4/5
30 Jin et al. [53] 2019 China Low and middle 460 Primary and secondary 14.80% 29.12 ± 4.36 5.60 ± 3.20 ZDS 3/5
31 Khademi et al. [54] 2005 Iran Low and middle 251 Primary and secondary 39.00% 29.60 ± 5.7 7.40 ± 4.6 BDI 4/5
32 Musa et al. [55] 2014 Malaysia Low and middle 123 Primary and secondary 31.70% NA NA DASS 4/5
\